Published in Biochem Biophys Res Commun on March 15, 1985
Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology (1986) 3.98
Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest (2007) 3.82
Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest (1987) 2.12
Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am (2010) 2.06
1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun (1998) 1.96
An inhibitor of the toxicity of tumour necrosis factor in the serum of patients with sarcoidosis, tuberculosis and Crohn's disease. Clin Exp Immunol (1990) 1.53
Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut (2000) 1.52
Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol (2010) 1.50
Vitamin D3: a helpful immuno-modulator. Immunology (2011) 1.46
Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol (2014) 1.40
The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol (2009) 1.40
Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells. J Clin Invest (1986) 1.29
Stat1-vitamin D receptor interactions antagonize 1,25-dihydroxyvitamin D transcriptional activity and enhance stat1-mediated transcription. Mol Cell Biol (2002) 1.25
Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates. BMC Genomics (2009) 1.22
1alpha,25-Dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol (2008) 1.19
Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. J Clin Invest (2002) 1.12
Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol (2000) 1.10
Stimulation of neutrophil respiratory burst and lysosomal enzyme release by human interferon-gamma. Immunology (1987) 1.10
Synthesis of the active metabolite of vitamin D, 1,25(OH)2D3, by synovial fluid macrophages in arthritic diseases. Ann Rheum Dis (1989) 1.08
Granulocyte-macrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes. J Clin Invest (1987) 1.07
1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis. J Clin Invest (1990) 1.00
Higher serum 25-hydroxyvitamin D concentrations associate with a faster recovery of skeletal muscle strength after muscular injury. Nutrients (2013) 0.95
1,25-Dihydroxyvitamin D3 modulates the expression of a lymphokine (granulocyte-macrophage colony-stimulating factor) posttranscriptionally. J Clin Invest (1988) 0.94
Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis. Respir Med (2010) 0.93
Hormones and the immune response. Ann Rheum Dis (1989) 0.88
MicroRNA-mediated mechanism of vitamin D regulation of innate immune response. J Steroid Biochem Mol Biol (2013) 0.85
Vitamin D receptor agonists target CXCL10: new therapeutic tools for resolution of inflammation. Mediators Inflamm (2013) 0.85
Immunomodulation by vitamin D: implications for TB. Expert Rev Clin Pharmacol (2011) 0.85
1,25-Dihydroxyvitamin D3 down-regulation of HLA-DR on human peripheral blood monocytes. Immunology (1992) 0.85
Elevated 1- α hydroxylase activity in monocytes from patients with active tuberculosis. Clin Dev Immunol (2013) 0.81
Differential metabolism of 25-hydroxyvitamin D3 by cultured synovial fluid macrophages and fibroblast-like cells from patients with arthritis. Ann Rheum Dis (1992) 0.81
1,25-Dihydroxyvitamin D3 transcriptionally regulates tumour necrosis factor mRNA during HL-60 cell differentiation. Immunology (1988) 0.81
Vitamin D receptor agonists: suitable candidates as novel therapeutic options in autoimmune inflammatory myopathy. Biomed Res Int (2014) 0.80
Inhibition by prostaglandin E1 and E2 of 1,25-dihydroxyvitamin D3 synthesis by synovial fluid macrophages from arthritic joints. Ann Rheum Dis (1992) 0.79
Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes. Immunology (1998) 0.79
1,25-dihydroxyvitamin D3 and development of tuberculosis in cattle. Clin Diagn Lab Immunol (2003) 0.76
Phagocytic cells synthesize 19-nor-10-keto-25-hydroxyvitamin D3, a metabolite that may induce differentiation of the human monoblastic cell line U937. Proc Natl Acad Sci U S A (1985) 0.75
The Vitamin D Receptor Regulates Tissue Resident Macrophage Response to Injury. Endocrinology (2016) 0.75
Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies. Front Immunol (2017) 0.75
Vitamin D and Infectious Diseases: Simple Bystander or Contributing Factor? Nutrients (2017) 0.75
Human p53 gene localized to short arm of chromosome 17. Nature (1986) 4.67
Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A (1987) 4.21
Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science (1978) 3.91
Effect of the normal microbial flora on gastrointestinal motility. Proc Soc Exp Biol Med (1967) 3.64
Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci U S A (1998) 3.46
The role of the vitamin D endocrine system in health and disease. N Engl J Med (1989) 3.37
Vitamin D deficiency inhibits pancreatic secretion of insulin. Science (1980) 3.00
Effect of the normal microbial flora on the resistance of the small intestine to infection. J Bacteriol (1966) 2.94
Amygdalin (Laetrile): effect on clonogenic cells from human myeloid leukemia cell lines and normal human marrow. Cancer Treat Rep (1980) 2.86
Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res (1998) 2.67
Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Nature (1986) 2.56
Structure-function relationships in the vitamin D endocrine system. Endocr Rev (1995) 2.54
Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res (2001) 2.53
Studies on the biological properties of polyene antibiotics. Evidence for the direct interaction of filipin with cholesterol. J Biol Chem (1972) 2.47
Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem (1999) 2.47
The association of a metabolite of vitamin D3 with intestinal mucosa chromatin in vivo. J Biol Chem (1968) 2.29
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest (1993) 2.25
A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J Cell Sci (1989) 2.17
Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol (1997) 2.09
A potential transcriptional activation element in the p53 protein. Oncogene (1990) 2.07
1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol (1984) 2.01
Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood (1983) 2.01
Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med (1981) 2.00
Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene (2008) 1.97
Human myeloid leukemia cell lines: a review. Blood (1980) 1.96
Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. Am J Clin Nutr (1998) 1.96
Absence of WAF1 mutations in a variety of human malignancies. Blood (1994) 1.95
p27/Kip1 mutation found in breast cancer. Cancer Res (1996) 1.94
The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr Rev (1982) 1.92
1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1987) 1.89
Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells. Blood (1996) 1.89
Myeloid transcription factor C/EBPepsilon is involved in the positive regulation of lactoferrin gene expression in neutrophils. Blood (1999) 1.88
An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood (1980) 1.86
Glycerolipid biosynthesis in peroxisomes via the acyl dihydroxyacetone phosphate pathway. Ann N Y Acad Sci (1982) 1.83
Kaposi's sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV8)-associated lymphoma of the bowel. Report of two cases in HIV-positive men with secondary effusion lymphomas. Am J Surg Pathol (1997) 1.79
Polyene antibiotic - sterol interaction. Adv Lipid Res (1976) 1.79
A method for the chemical synthesis of 14C-labeled fatty acyl coenzyme A's of high specific activity. Anal Biochem (1980) 1.78
Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood (1995) 1.76
Characterization of cDNA clones for human myeloperoxidase: predicted amino acid sequence and evidence for multiple mRNA species. Nucleic Acids Res (1987) 1.67
Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphoma. Leukemia (2006) 1.67
Detection of pituitary microadenomas: comparison of dynamic keyhole fast spin-echo, unenhanced, and conventional contrast-enhanced MR imaging. AJR Am J Roentgenol (1994) 1.61
Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology (1986) 1.57
25-Hydroxyvitamin D3 metabolism by lipopolysaccharide-stimulated normal human macrophages. J Clin Endocrinol Metab (1987) 1.54
Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood (1997) 1.54
Molecular genetic advances in chronic myelogenous leukemia. Ann Intern Med (1990) 1.54
Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J Biol Chem (2001) 1.52
Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood (2001) 1.50
1,25-dihydroxycholecalciferol and 1alpha-hydroxycholecalciferol in hypoparathyroidism. Lancet (1974) 1.49
BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1). Oncogene (2006) 1.48
DNA aneuploidy in morphologically normal colons from patients with colon cancer. Mod Pathol (1995) 1.48
Why fat is bright in RARE and fast spin-echo imaging. J Magn Reson Imaging (1992) 1.46
CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. J Clin Invest (1999) 1.45
Age-related changes in the proportion of types I and III collagen. Mech Ageing Dev (1988) 1.44
Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines. Cancer Res (1997) 1.44
Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins. Mol Cell Biol (1999) 1.43
Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood (1995) 1.42
Parathyroidectomy in secondary (renal) hyperparathyroidism--whom, when, how? Int J Artif Organs (1993) 1.41
Myeloperoxidase: its structure and expression during myeloid differentiation. Blood (1985) 1.41
Characterization of a novel HTLV-infected cell line. Blood (1984) 1.40
Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man. N Engl J Med (1972) 1.39
Rapidly progressive glomerulonephritis in a patient with Henoch-Schoenlein purpura. Spontaneous recovery of renal function after six months of maintenance hemodialysis. Clin Nephrol (1995) 1.39
Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. Blood (2000) 1.38
Determination of CD4 antigen density on cells: role of antibody valency, avidity, clones, and conjugation. Cytometry (1998) 1.38
An hydroxylapatite batch assay for the quantitation of 1alpha,25-dihydroxyvitamin D3-receptor complexes. Anal Biochem (1979) 1.38
1,25(OH)2-vitamin D3 receptors: gene regulation and genetic circuitry. FASEB J (1988) 1.37
Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res (1984) 1.37
p53 in hematologic malignancies. Blood (1994) 1.37
Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. J Biol Chem (2000) 1.37
Regulation of expression of murine transferrin receptor 2. Blood (2001) 1.35
Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest (1984) 1.34
Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res (1990) 1.33
Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation. Cancer Res (1981) 1.33
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood (1996) 1.33
Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells. J Clin Invest (1982) 1.33
p53 mutations in human lung tumors. Cancer Res (1992) 1.33
Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol. J Clin Invest (1975) 1.33
The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene (2007) 1.32
N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome. Blood (1993) 1.32
Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer. Cancer Res (2000) 1.30
Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood (1998) 1.30
Gamma-interferon induces expression of the HLA-D antigens on normal and leukemic human myeloid cells. Proc Natl Acad Sci U S A (1984) 1.29
Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells. J Clin Invest (1986) 1.29
Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification. Cancer Res (1993) 1.29
1alpha,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J (2001) 1.29
A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation. Blood (1997) 1.29
Dlk1 in normal and abnormal hematopoiesis. Leukemia (2005) 1.28
Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood (1998) 1.28
1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood (1993) 1.28
Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem (2001) 1.28
Vitamin D: A cholecalciferol metabolite highly active in promoting intestinal calcium transport. Science (1971) 1.28
Vitamin D: metabolism and biological actions. Annu Rev Nutr (1984) 1.27